Nalaganje...
Inflammatory bowel disease: towards a personalized medicine
The management of inflammatory bowel disease (IBD) has been transformed over the last two decades by the arrival of tumor necrosis factor (TNF) antagonist agents. Recently, alternative drugs have been approved, directed at leukocyte-trafficking molecules (vedolizumab) or other inflammatory cytokines...
Shranjeno v:
| izdano v: | Therap Adv Gastroenterol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SAGE Publications
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5784543/ https://ncbi.nlm.nih.gov/pubmed/29383027 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756283X17745029 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|